Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report contains market size and forecasts of Anti-Inflammatory Analgesic and Antipyretic Drugs in global, including the following market information:
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Anti-Inflammatory Analgesic and Antipyretic Drugs companies in 2022 (%)
The global Anti-Inflammatory Analgesic and Antipyretic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Paracetamol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Type, 2022 (%)
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues share in global market, 2022 (%)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Overall Market Size
2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size: 2022 VS 2030
2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market
3.2 Top Global Anti-Inflammatory Analgesic and Antipyretic Drugs Companies Ranked by Revenue
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Companies
3.4 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Companies
3.5 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Markets, 2022 & 2030
4.1.2 Paracetamol
4.1.3 Aspirin
4.1.4 Ibuprofen
4.1.5 Naproxen
4.1.6 Diclofenac
4.1.7 Oxaprozin
4.1.8 Dexibuprofen
4.1.9 Others
4.2 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2023-2030
4.2.3 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2023-2030
4.3.3 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2023-2030
5.2.3 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2023-2030
5.3.3 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2023-2030
6.2.3 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2023-2030
6.3.3 By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030
6.4.2 By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2030
6.4.3 US Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.4.4 Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.4.5 Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2030
6.5.3 Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.4 France Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.5 U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.6 Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.7 Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.5.9 Benelux Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2030
6.6.3 China Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.6.4 Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.6.5 South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.6.7 India Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030
6.7.2 By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2030
6.7.3 Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.7.4 Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2030
6.8.3 Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.8.4 Israel Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
6.8.6 UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Corporate Summary
7.1.2 Mallinckrodt Pharmaceuticals Business Overview
7.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.1.4 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Mallinckrodt Pharmaceuticals Key News
7.2 IOL
7.2.1 IOL Corporate Summary
7.2.2 IOL Business Overview
7.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.2.4 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 IOL Key News
7.3 Anqiu Lu'an Pharmaceutical
7.3.1 Anqiu Lu'an Pharmaceutical Corporate Summary
7.3.2 Anqiu Lu'an Pharmaceutical Business Overview
7.3.3 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.3.4 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Anqiu Lu'an Pharmaceutical Key News
7.4 Novacyl
7.4.1 Novacyl Corporate Summary
7.4.2 Novacyl Business Overview
7.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.4.4 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novacyl Key News
7.5 BASF
7.5.1 BASF Corporate Summary
7.5.2 BASF Business Overview
7.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.5.4 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 BASF Key News
7.6 Anhui BBCA Pharmaceuticals
7.6.1 Anhui BBCA Pharmaceuticals Corporate Summary
7.6.2 Anhui BBCA Pharmaceuticals Business Overview
7.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.6.4 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Anhui BBCA Pharmaceuticals Key News
7.7 Hubei Biocause
7.7.1 Hubei Biocause Corporate Summary
7.7.2 Hubei Biocause Business Overview
7.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.7.4 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hubei Biocause Key News
7.8 Xinhua Pharm
7.8.1 Xinhua Pharm Corporate Summary
7.8.2 Xinhua Pharm Business Overview
7.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.8.4 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Xinhua Pharm Key News
7.9 Granules India Limited
7.9.1 Granules India Limited Corporate Summary
7.9.2 Granules India Limited Business Overview
7.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.9.4 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Granules India Limited Key News
7.10 Huagang Pharm
7.10.1 Huagang Pharm Corporate Summary
7.10.2 Huagang Pharm Business Overview
7.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.10.4 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Huagang Pharm Key News
7.11 Hebei Jiheng Pharmaceutical
7.11.1 Hebei Jiheng Pharmaceutical Corporate Summary
7.11.2 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.11.4 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Hebei Jiheng Pharmaceutical Key News
7.12 Zhejiang Kangle Pharmaceutical
7.12.1 Zhejiang Kangle Pharmaceutical Corporate Summary
7.12.2 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.12.4 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Zhejiang Kangle Pharmaceutical Key News
7.13 Hebei Jingye Medical Technology
7.13.1 Hebei Jingye Medical Technology Corporate Summary
7.13.2 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.13.4 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Hebei Jingye Medical Technology Key News
7.14 MSPF
7.14.1 MSPF Corporate Summary
7.14.2 MSPF Business Overview
7.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.14.4 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.14.5 MSPF Key News
7.15 Lu'an Pharmaceutical
7.15.1 Lu'an Pharmaceutical Corporate Summary
7.15.2 Lu'an Pharmaceutical Business Overview
7.15.3 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.15.4 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Lu'an Pharmaceutical Key News
7.16 Mallinckrodt
7.16.1 Mallinckrodt Corporate Summary
7.16.2 Mallinckrodt Business Overview
7.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.16.4 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Mallinckrodt Key News
7.17 Farmson
7.17.1 Farmson Corporate Summary
7.17.2 Farmson Business Overview
7.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.17.4 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Farmson Key News
7.18 Anhui Fubore
7.18.1 Anhui Fubore Corporate Summary
7.18.2 Anhui Fubore Business Overview
7.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.18.4 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Anhui Fubore Key News
7.19 SKPL
7.19.1 SKPL Corporate Summary
7.19.2 SKPL Business Overview
7.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.19.4 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.19.5 SKPL Key News
7.20 Atabay
7.20.1 Atabay Corporate Summary
7.20.2 Atabay Business Overview
7.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.20.4 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Atabay Key News
7.21 Huzhou Konch Pharmaceutical
7.21.1 Huzhou Konch Pharmaceutical Corporate Summary
7.21.2 Huzhou Konch Pharmaceutical Business Overview
7.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.21.4 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Huzhou Konch Pharmaceutical Key News
7.22 Anhui Topsun
7.22.1 Anhui Topsun Corporate Summary
7.22.2 Anhui Topsun Business Overview
7.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.22.4 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Anhui Topsun Key News
7.23 SOLARA
7.23.1 SOLARA Corporate Summary
7.23.2 SOLARA Business Overview
7.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.23.4 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.23.5 SOLARA Key News
7.24 SI Group
7.24.1 SI Group Corporate Summary
7.24.2 SI Group Business Overview
7.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.24.4 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.24.5 SI Group Key News
8 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity, Analysis
8.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity, 2018-2030
8.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Inflammatory Analgesic and Antipyretic Drugs Supply Chain Analysis
10.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Value Chain
10.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Upstream Market
10.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs in Global Market
Table 2. Top Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Companies, (Tons), 2018-2023
Table 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Product Type
Table 9. List of Global Tier 1 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 15. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2023-2030
Table 16. By Application ? Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 20. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2023-2030
Table 21. By Region ? Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 25. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2023-2030
Table 26. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 29. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2023-2030
Table 30. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 33. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2023-2030
Table 34. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 37. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2023-2030
Table 38. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 41. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2023-2030
Table 42. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2023-2030
Table 46. Mallinckrodt Pharmaceuticals Corporate Summary
Table 47. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 48. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. IOL Corporate Summary
Table 50. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 51. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 52. Anqiu Lu'an Pharmaceutical Corporate Summary
Table 53. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 54. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 55. Novacyl Corporate Summary
Table 56. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 57. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 58. BASF Corporate Summary
Table 59. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 60. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Anhui BBCA Pharmaceuticals Corporate Summary
Table 62. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 63. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 64. Hubei Biocause Corporate Summary
Table 65. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 66. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 67. Xinhua Pharm Corporate Summary
Table 68. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 69. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 70. Granules India Limited Corporate Summary
Table 71. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 72. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Huagang Pharm Corporate Summary
Table 74. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 75. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 76. Hebei Jiheng Pharmaceutical Corporate Summary
Table 77. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 78. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 79. Zhejiang Kangle Pharmaceutical Corporate Summary
Table 80. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 81. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 82. Hebei Jingye Medical Technology Corporate Summary
Table 83. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 84. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. MSPF Corporate Summary
Table 86. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 87. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 88. Lu'an Pharmaceutical Corporate Summary
Table 89. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 90. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 91. Mallinckrodt Corporate Summary
Table 92. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 93. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 94. Farmson Corporate Summary
Table 95. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 96. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Anhui Fubore Corporate Summary
Table 98. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 99. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 100. SKPL Corporate Summary
Table 101. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 102. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 103. Atabay Corporate Summary
Table 104. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 105. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 106. Huzhou Konch Pharmaceutical Corporate Summary
Table 107. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 108. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 109. Anhui Topsun Corporate Summary
Table 110. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 111. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 112. SOLARA Corporate Summary
Table 113. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 114. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 115. SI Group Corporate Summary
Table 116. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 117. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 118. Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2023 (Tons)
Table 119. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Capacity Market Share of Key Manufacturers, 2020-2023
Table 120. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region, 2018-2023 (Tons)
Table 121. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region, 2023-2030 (Tons)
Table 122. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Opportunities & Trends in Global Market
Table 123. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers in Global Market
Table 124. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints in Global Market
Table 125. Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Materials
Table 126. Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Materials Suppliers in Global Market
Table 127. Typical Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream
Table 128. Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream Clients in Global Market
Table 129. Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Type
Figure 2. Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Application
Figure 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Anti-Inflammatory Analgesic and Antipyretic Drugs Sales in Global Market: 2018-2030 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 10. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton), 2018-2030
Figure 12. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 13. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 14. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton), 2018-2030
Figure 15. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 16. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 17. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 18. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 19. US Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 24. Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. France Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 33. China Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. India Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 39. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 40. Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2030
Figure 44. Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2030
Figure 48. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity (Tons), 2018-2030
Figure 49. The Percentage of Production Anti-Inflammatory Analgesic and Antipyretic Drugs by Region, 2022 VS 2030
Figure 50. Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Value Chain
Figure 51. Marketing Channels
